H. Stockinger, S. J. Gadd, R. Eher, O. Madjdic, et al., “Molecular Characterization and Functional Analysis of the Leukocyte Surface Protein CD31,” Journal of Immunology, Vol. 11, 1990, pp. 3889-3897.
 S. Albelda, W. Muller, C. Buck and P. Newman, “Mo-lecular and Cellular Properties of PECAM-1 (Endo-cam/CD31): A Novel Vascular Cell-Cell Adhesion Molecule,” Journal of Cell Biology, Vol. 114, 1991, pp. 1059- 1068.
 J. C. Fawcett, C. L. Buckley, I. N. Holness, J. H. Bird, J. Spragg and A. Sauders, “Mapping the Homotipic Binding Sites in CD31 and the Role of CD31 in the Formation of Interendothelial Cells Contacts,” Journal of Cell Biology, Vol. 128, 1995, pp. 1229-1241.
 L. Piali, P. Hammel, C. Uherek, et al., “CD31/PECAM-1 Is a Ligand for Alpha V Beta 3 Integrin Involved In Ad-hesion of Leukocytes to Endothelium,” Journal of Cell Biology, Vol. 130, 1995, pp. 451-460.
 R. Chiba, N. Nakagawa, K. Kurasawa, Y. Tanaka, Y. Saito and I. Iwamoto, “Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of Al-phavbeta3 Integrin and Enhances Beta1 Integrin- Mediated Adhesion of Eosinophils to Endothelial Cells,” Blood, Vol. 94, 1999, pp. 1319-1329.
 H. DeLisser, H. Yan, P. Newman, W. Muller, C. Buck, S. Albelda, “Platelet/endothelial Cell Adhesion Molecule-1 (CD31)-Mediated Cellular Aggregation Involves Cell Surface Glycosaminoglycans,” Journal of Biological Chemistry, Vol. 268, 1993, pp. 16037-16046.
 N. Ilan, L. Cheung, E. Pinter and J. A. Madri, “Platelet- Endothelial Cell Adhesion Molecule-1 (CD31), a Scaf-folding Molecule for Selected Catenin Family Members Whose Binding Is Mediated by Different Tyrosine and Serine/Threonine Phosphorylation,” Journal of Biological Chemistry, Vol. 275, 2000, pp. 21435-21443.
 S. Bogen, J. Pak, M. Garifallou, X. Deng and W. Muller, “Monoclonal Antibody to Murine PECAM-1 (CD31) Blocks Acute Inflammation in Vivo,” Journal of Experi-mental Medicine, Vol. 179, 1994, pp. 1059-1064.
 J. L. Zehnder, M. Shatsky, L. L. K. Leung, E. C. Batcher, et al., “Involvement of CD31 in Lymphocyte Mediated Inmune Responses: Importance of the Membrane Proximal Immunoglobuline Domain and Identification of an Inhibiting CD31 Peptide,” Blood, Vol. 85, 1995, pp. 1282-1288.
 V. Lutzky, R. Carnevale, M. Alvarez, P. Maffia, S. Zit-termann, O. Podhajcer. et al., “Platelet-Endothelial Cell Adhesion Molecule-1 (CD31) Recycles and Induces Cell Growth Inhibition on Human Tumor Cell Lines,” Journal of Cell Biochemistry, Vol. 98, 2005, pp. 1334-1350.
 S. Kondo, E. Scheef, N. Sheibani and C. Sorenson, “PECAM-1 Isoform-Specific Regulation of Kidney En-dothelial Cell Migration and Capillary Morphogenesis,” American Journal of Physiology, Vol. 292, 2007, pp. 2070-2083.
 C. Bergom, R. Goel, C. Paddock, C. Gao, D. K. Newman, S. Matsuyama and P. J. Newman, “The Cell-Adhesion and Signaling Molecule PECAM-1 Is a Molecular Mediator of Resistance to Genotoxic Chemotherapy,” Cancer Biology & Therapy, Vol. 5, No. 12, 2006, pp. 1699-1707.
 S. Ibrahim, I. Jilani, S. O’Brien, A. Rogers, T. Manshouri, F. Giles, et al., “Clinical Relevance of the Expression of the CD31 Ligand for CD38 in Patients with B-Cell Chronic Lymphocytic Leukemia,” American Cancer So-ciety, Vol. 97, No. 8, 2003, pp. 1914-1919.
 A. Darom, I. Gomatos, E. Leandros, E. Chatzigianni, D. Panousopoulos, Konstadoulakis and G. Androulakis, “Molecular Markers (PECAM-1, ICAM-3, HLA-DR) Determine Prognosis in Primary Non-Hodgkin’s Gastric Lymphoma Patients,” World Journal of Gastroenterology, Vol. 12, No. 12, 2006, pp. 1924-1932.
 D. Tang, Y. Chen, P. Newman, et al., “Identification of PECAM-1 in Solid Tumour Cells and Its Potential In-volvement in Tumour Cell Adhesion to Endothelium,” Journal of Biological Chemistry, Vol. 268, 1993, pp. 22883-22894.
 S. Fox, G. Turner, R. Leek, R. Whitehouse, K. Gatter and A. Harris, “The Prognostic Value of Quantitative Angio-genesis in Breast Cancer and Role of Adhesion Molecule Expression in Tumour Endothelium,”Breast Cancer Re-search and Treatment, Vol. 36, 1995, pp. 219-226.
 T. Vlaykova, P. Laurila, T. Muhonen, M. Hahka- kemp-pinen, et al., “Prognostic Value of Tumour Vascularity in Metastatic Melanoma and Association of Blood Vessel Density with Vascular Endothelial Growth Factor Expres-sion,” Melanoma Research, Vol. 9, 1999, pp. 59-68.
 A. Pisacane, F. Picciotto and M. Risio, “CD31 and CD34 Expression as Immunohistochemical Markers of Endo-thelial Transdifferentiation in Human Cutaneous Mela-noma,” Cellular Oncology, Vol. 29, 2007, pp. 59-66.